Seattle Genetics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SGEN Nasdaq 8731 http://www.seattlegenetics.com/ 65.09 Stock Down -1.55

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Seattle Genetics, Inc.

3:09 am Seattle Genetics and Bristol-Myers Squibb (BMY) highlight first data from Phase 1/2 study evaluating ADCETRIS; data showed 90% Objective Response Rate and 62% Complete Response Rate - Dec 6th, 2016 1:09 am